Clinical Research
Heart Failure
Incremental Prognostic Significance of Peripheral Endothelial Dysfunction in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction

https://doi.org/10.1016/j.jacc.2012.07.036Get rights and content
Under an Elsevier user license
open archive

Objectives

The purpose of this study was to investigate whether peripheral endothelial dysfunction could predict the occurrence of cardiovascular events in patients with heart failure (HF) with normal left ventricular ejection fraction (HFNEF).

Background

Endothelial dysfunction plays an important role in HF, but the relation between peripheral endothelial dysfunction and prognosis in HFNEF remains unknown.

Methods

We conducted a prospective cohort study of 321 patients with HFNEF. We evaluated cardiac function by echocardiography measuring the ratio of early transmitral flow velocity to tissue Doppler early diastolic mitral annular velocity (E/e'), noninvasively assessed peripheral endothelial function by reactive hyperemia-peripheral arterial tonometry (RH-PAT) as the RH-PAT index (RHI), and followed cardiovascular events.

Results

A total of 59 patients had a cardiovascular event. Kaplan-Meier analysis demonstrated a significantly higher probability of cardiovascular events in the low RHI group than in the high RHI group (mean follow-up: 20 months; log-rank test: p < 0.001). Multivariate Cox hazard analysis identified RHI (per 0.1) (hazard ratio [HR]: 0.80; 95% confidence interval [CI]: 0.67 to 0.94; p = 0.007), E/e' (Ln[E/e'] [per 0.1]) (HR: 1.15; 95% CI: 1.04 to 1.26; p = 0.006), and B-type natriuretic peptide (BNP) (Ln[BNP] [per picogram/milliliter]) (HR: 1.81; 95% CI: 1.44 to 2.28; p < 0.001) as independent predictors of cardiovascular events. The C-statistics for cardiovascular events substantially increased when the RHI was added to the HFNEF prognostic 5 factors (PF5)—age, diabetes, New York Heart Association classification, HF hospitalization history, and left ventricular ejection fraction—which were identified in the I-PRESERVE (Irbesartan in Heart Failure with Preserved Ejection Fraction Study) (PF5 alone: 0.671; PF5 + RHI: 0.712). The net reclassification index was significant after addition of the RHI (19.0%, p = 0.01).

Conclusions

Peripheral endothelial dysfunction independently correlated with future cardiovascular events, adding incremental clinical significance for risk stratification in patients with HFNEF. (Endothelial Dysfunction Assessed by Reactive Hyperemia Peripheral Arterial Tonometry and Heart Failure with Preserved Left Ventricular Ejection Fraction; UMIN000002640)

Key Words

endothelial function
heart failure with normal left ventricular ejection fraction
reactive hyperemia-peripheral arterial tonometry

Abbreviations and Acronyms

AHFS
acute heart failure syndrome
BMI
body mass index
BNP
B-type natriuretic peptide
CI
confidence interval
DM
diabetes mellitus
E/e'
ratio of early transmitral flow velocity to tissue Doppler early diastolic mitral annular velocity
eGFR
estimated glomerular filtration rate
HF
heart failure
HFNEF
heart failure with normal left ventricular ejection fraction
HFREF
heart failure with reduced left ventricular ejection fraction
HR
hazard ratio
LV
left ventricular
LVDD
left ventricular diastolic dysfunction
LVEF
left ventricular ejection fraction
NRI
net reclassification index
NT-proBNP
N-terminal pro-B-type natriuretic peptide
NYHA
New York Heart Association
OR
odds ratio
PF5
HFNEF prognostic 5 factors
RHI
reactive hyperemia-peripheral arterial tonometry index
RH-PAT
reactive hyperemia-peripheral arterial tonometry

Cited by (0)

Funding: This study was supported in part by a grant-in-aid for Scientific Research (No. C22590786 for S. Sugiyama) from the Ministry of Education, Science, and Culture in Japan. All authors have reported that they have no relationships relevant to the contents of this paper to disclose.